Direktorat Registrasi ObatValid

PEMETREXED DISODIUM HEMIPENTAHYDRATE

Claim this product
BPOM Number
GKL1943901544A1
Approved
19 June 2025
Expiry
18 March 2030
Form
SERBUK INJEKSI LIOFILISASI

About This Registration

PEMETREXED DISODIUM HEMIPENTAHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1943901544A1. Its current registration status is Valid, with the licence valid until 18 March 2030. The product is registered to CKD OTTO PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in June 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 1 VIAL @ 100 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

PEMETREXED DISODIUM HEMIPENTAHYDRATE

Market Intelligence

Owner Portfolio
CKD OTTO PHARMACEUTICALS - INDONESIA holds 49 BPOM registrations
Manufacturer Scale
CKD OTTO PHARMACEUTICALS - INDONESIA produces 49 registered products
Registration Age
Registered for 1 year, 2 months

FDA Cross-Reference

via openFDA
Generic Name
PEMETREXED DISODIUM
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from CKD OTTO PHARMACEUTICALS - INDONESIA

BELLVESTRANT

-DKI2699801143A1
Valid
Approved: Aug 16, 2026INJEKSI
View product →

BEVABELL

-DKI2570200149A1
Valid
Approved: May 9, 2026LARUTAN KONSENTRAT UNTUK INFUS
View product →

BORTEZOMIB

-GKL2543902044B1
Valid
Approved: Dec 28, 2025SERBUK INJEKSI LIOFILISASI
View product →

TEZOBELL

-DKL2543901944B1
Valid
Approved: Dec 28, 2025SERBUK INJEKSI LIOFILISASI
View product →

MYREPT

-DKI2584401309A1
Valid
Approved: Aug 31, 2025KAPLET SALUT SELAPUT
View product →

Products in the same class

GOUTRIC

-DKL0615205410A1
Valid
Approved: Aug 16, 2026TABLET
MEGA ESA FARMA - INDONESIA
View product →

FEBULORIC 80

-DKL2604136517B1
Valid
Approved: Apr 10, 2026TABLET SALUT SELAPUT
COMBIPHAR
View product →

DICOREN

-DTL2042800828A1
Valid
Approved: Sep 30, 2025GEL
YSP INDUSTRIES INDONESIA - INDONESIA
View product →

BRONCHITIN EXPECTORANT

-DTL1818217737A1
Valid
Approved: Aug 27, 2025SIRUP
NUFARINDO - INDONESIA
View product →

MILLSEN

-DTL0123405337A1
Valid
Approved: May 12, 2025SIRUP
SAMPHARINDO PERDANA - INDONESIA
View product →
1